ArticleBiochemistry and biophysics reports2026
Scoparone protects against acetaminophen-induced acute liver injury: Insights from In vivo experiments and RNA sequencing.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Scoparone (Sco) is known for its therapeutic effects in alleviating liver injury. This study aims to investigate the protective effects of Sco against acetaminophen-induced acute liver injury (ALI) and explore its underlying mechanisms through in vivo experiments and RNA sequencing. Methods: Male Wistar rats were administered acetaminophen (400 mg/kg) to induce ALI, and Sco was given as an intervention. Liver injury and Sco's therapeutic efficacy were evaluated using histopathological analysis and biochemical indicators. RNA sequencing of liver tissue was performed to explore the molecular mechanisms, and differentially expressed genes were validated by qRT-PCR and in silico analysis. Results: Histopathological analysis showed that Sco alleviated liver injury caused by acetaminophen. RNA sequencing identified 50 mRNAs and 93 lncRNAs whose expression was significantly altered by acetaminophen, with Sco reversing these changes. Gene enrichment analysis revealed that Sco counteracted alterations in genes involved in the Glycolysis/Gluconeogenesis pathway and the "external side of plasma membrane" GO term, which were induced by acetaminophen. Moreover, 17 lncRNA-mRNA pairs potentially associated with Sco-mediated liver protection were identified. qPCR validation confirmed the RNA sequencing results. In silico analysis suggested that Conclusions: This study demonstrates that Scoparone effectively protects the liver from acetaminophen-induced injury. The results provide novel insights into the anti-inflammatory and antioxidative effects of Sco and suggest it as a potential therapeutic strategy for liver injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.